Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18,680 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk factors and in-hospital mortality in Chinese patients undergoing coronary artery bypass grafting: analysis of a large multi-institutional Chinese database.
Zheng Z, Zhang L, Hu S, Li X, Yuan X, Gao H; Chinese Cardiovascular Surgical Registry Study. Zheng Z, et al. Among authors: hu s. J Thorac Cardiovasc Surg. 2012 Aug;144(2):355-9, 359.e1. doi: 10.1016/j.jtcvs.2011.10.012. Epub 2011 Nov 5. J Thorac Cardiovasc Surg. 2012. PMID: 22056490 Free article.
Outline of the report on cardiovascular disease in China, 2010.
Hu SS, Kong LZ, Gao RL, Zhu ML, Wang W, Wang YJ, Wu ZS, Chen WW, Liu MB; Editorial Board. Hu SS, et al. Biomed Environ Sci. 2012 Jun;25(3):251-6. doi: 10.3967/0895-3988.2012.03.001. Biomed Environ Sci. 2012. PMID: 22840574 Free article.
Mortality risk model for heart valve surgery in China.
Zheng Z, Fan H, Gao H, Li X, Yuan X, Meng J, Xu J, Song Y, Sun H, Hu S. Zheng Z, et al. Among authors: hu s. J Heart Valve Dis. 2013 Jan;22(1):93-101. J Heart Valve Dis. 2013. PMID: 23610996
Rationale and design of a randomized cluster trial to improve guideline-adherence of secondary preventive drugs prescription after coronary artery bypass grafting in China: Measurement and Improvement Studies of Surgical Coronary Revascularization: Secondary Prevention (MISSION-1) Study.
Rao C, Du J, Li X, Li J, Zhang H, Zhao Y, Hu S, Jiang L, Zheng Z; MISSION-1 Collaborative Group. Rao C, et al. Among authors: hu s. Am Heart J. 2016 Aug;178:9-18. doi: 10.1016/j.ahj.2016.01.014. Epub 2016 Jan 25. Am Heart J. 2016. PMID: 27502847 Clinical Trial.
18,680 results
You have reached the last available page of results. Please see the User Guide for more information.